Avecho Biotechnology Limited (ASX:AVE)
Australia · Delayed Price · Currency is AUD 0.0130
+0.0010 (8.33%)
May 8, 2026, 4:10 PM AEST
Avecho Biotechnology Market Cap
Avecho Biotechnology has a market cap or net worth of 47.76 million as of May 8, 2026. Its market cap has increased by 200.96% in one year.
Market Cap
47.76M
Enterprise Value
43.11M
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since February 28, 1996, Avecho Biotechnology's market cap has increased from 39.36M to 47.76M, an increase of 21.34%. That is a compound annual growth rate of 0.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 47.76M | 44.44% |
| Dec 31, 2025 | 33.06M | 317.27% |
| Dec 31, 2024 | 7.92M | -28.57% |
| Dec 29, 2023 | 11.09M | -59.76% |
| Dec 30, 2022 | 27.57M | 0.10% |
| Dec 30, 2021 | 27.54M | -40.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 79.07M |
| Botanix Pharmaceuticals | 73.45M |
| Radiopharm Theranostics | 67.34M |
| Amplia Therapeutics | 66.70M |
| Entropy Neurodynamics | 59.56M |
| Prescient Therapeutics | 56.78M |
| Neurizon Therapeutics | 56.40M |
| Imugene | 42.35M |